Improving Pneumococcal Vaccine

To compare the immunogenicity of current vaccines for pneumococcal disease (native pneumococcal polysaccharide vaccine) with a proposed new vaccination method (microsphere entrapped pneumococcal capsular polysaccharides delivered either subcutaneously or intranasally).
Funding Partners:
  • Georgia Research Alliance
Program Partners:
  • CDC's National Center for Immunization and Respiratory Diseases
  • Emory University
  • Mercer University
Program Location:
  • United States of America